Several leading private hospitals across India are reportedly considering withdrawing from government-funded health insurance schemes including Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) citing financial stress caused by low treatment package rates and delayed reimbursements. Hospital industry representatives say that the current reimbursement structure under government health schemes has become increasingly unsustainable for many large private healthcare providers particularly tertiary and super-speciality hospitals that handle complex cases requiring advanced infrastructure and high operational costs.
According to industry estimates, package rates under certain government schemes have not seen substantial revisions for several years despite rising medical inflation, increased manpower expenses, higher equipment costs and growing compliance requirements. Hospital operators argue that the gap between actual treatment costs and government reimbursement rates has widened significantly.
Healthcare associations have reportedly raised concerns with both central and state authorities warning that continued financial pressure could force many major hospitals to either limit the number of scheme beneficiaries they treat or completely exit government empanelment programmes. Private hospitals play a crucial role in India’s public healthcare delivery ecosystem particularly under schemes such as Ayushman Bharat where empanelled hospitals provide cashless treatment to eligible low-income families. Experts say any large-scale withdrawal by major private healthcare institutions could significantly impact patient access to advanced medical care.
Hospital administrators point out that high-end procedures involving cardiac care, oncology, critical care, neurosurgery and organ support systems often cost substantially more than the fixed package reimbursements offered under government schemes. They argue that while smaller routine procedures may remain manageable, tertiary care services are becoming financially difficult to sustain under existing pricing structures.
Another major issue raised by hospitals is delayed claim settlement and administrative bottlenecks. Industry representatives say payment delays affect operational cash flow and increase financial strain particularly for hospitals handling large volumes of government scheme patients. Healthcare experts note that the tension reflects a larger challenge within India’s healthcare financing system — balancing affordable treatment for patients while ensuring financial viability for healthcare providers. While government insurance schemes have expanded healthcare access for millions of people, private hospitals argue that pricing mechanisms must evolve to reflect current market realities and quality standards.
Some healthcare analysts believe the issue could trigger broader discussions around healthcare cost standardisation, dynamic pricing models and differentiated package structures based on hospital capability and complexity of care. Public health experts caution that any disruption in private hospital participation could place additional pressure on government hospitals, many of which are already burdened with high patient volumes and limited resources. Officials, however, maintain that government health schemes remain essential for ensuring healthcare access to economically vulnerable populations and say efforts are ongoing to improve efficiency, transparency and reimbursement systems.
